Legal advisor to Bonusan on strategic partnership with bd-capital

Acted as legal advisor to Bonusan in connection with its strategic partnership with bd-capital.

Bonusan is a Dutch healthcare company with a long-standing position in food supplements and knowledge development for healthcare professionals. The partnership with bd-capital was aimed at supporting further growth in the Netherlands and across Europe, while preserving Bonusan’s quality standards and knowledge base. Bonusan announced that the partnership was intended to accelerate its ambitions and increase the positive impact of Bonusan and Natura Foundation. bd-capital describes Bonusan as a leading Dutch producer of nutritional supplements and healthcare solutions.

The legal work included transaction structuring, investment documentation, shareholder arrangements and implementation of the partnership structure. Strategic partnerships with financial investors require clear arrangements on governance, growth, decision-making, information rights, exit and continuity of the business.

Need legal advice on a partnership with an investor?

For questions about private equity investments, strategic partnerships, shareholder arrangements or investment documentation, please contact dirk.dewaard@viottalaw.com.

Deal highlights

Transaction type – Strategic partnership / private equity investment

Client – Bonusan

Investor – bd-capital

Sector – Healthcare / nutritional supplements

Role – Legal advisor to Bonusan

Legal work – Transaction structure, investment documentation, shareholder arrangements and implementation

External links

Dealmaker — bd-capital acquires stake in Bonusan
Bonusan — Bonusan kiest voor samenwerking met bd-capital
bd-capital — Bonusan

Related expertise

Private equity
Investment agreement
Shareholders agreement
Corporate / M&A

Involved lawyers.

If you need a legal opinion under Dutch law, please do not hesitate to contact us via
info@viottalaw.com or +31 20 248 06 00.

By VIOTTA.

Recent cases.

By VIOTTA.

More articles.

16 / 10 2026

Lessons from Cross-Border Transactions: Dutch Deal Execution in Practice

Practical observations from cross-border transactions involving Dutch companies, focusing on transaction management, drafting, due diligence, closing mechanics and Dutch implementation.

READ ARTICLE
16 / 10 2026

Preparing a Dutch Company for Investment or Sale

A practical Dutch deal-readiness guide covering ownership, governance, contracts, IP, management incentives, corporate approvals and data-room preparation before an investment or sale.

READ ARTICLE
15 / 10 2026

VC Term Sheets in Dutch Financing Rounds: What Is Binding and What Is Not?

A practical insight for international investors and counsel on Dutch VC term sheets: which commercial terms remain non-binding, which process provisions should bind immediately and how the term sheet moves into Dutch BV financing documentation.

READ ARTICLE
08 / 10 2026

Can a Dutch NV Remain TopCo for a Nasdaq Listing? The InoBat Structure

The proposed InoBat transaction shows how a Dutch N.V. can serve as TopCo in a Nasdaq structure involving preference shares, warrants, employee options and PIPE financing.

READ ARTICLE
08 / 10 2026

Digital Shareholder Meetings in Dutch Companies from 2027

From 1 January 2027, Dutch companies can use fully digital shareholder meetings if the articles and meeting process meet the statutory requirements. The change is relevant for international shareholder governance and transaction approvals.

READ ARTICLE
08 / 10 2026

Share Options for Dutch Employees Under a Foreign Parent Company Plan

Foreign parent companies can grant options to employees of a Dutch subsidiary. This insight explains the Dutch implementation layer: local documentation, grant administration, employee mobility and the treatment of Dutch participants in a group exit.

READ ARTICLE